Skip to main content
. 2020 May 15;24(13):7201–7213. doi: 10.1111/jcmm.15230

FIGURE 4.

FIGURE 4

Magnesium isoglycyrrhizinate (MGIG) treatment improved hepatic steatosis by promoting lipid metabolism. The hepatic levels of NAD+, NADH and NAD+/NADH ratio (A). The protein expression of deacetylase sirtuin 1 (Sirt1) and its quantification data in liver samples (B). The lipid synthesis‐related genes expressions (C). The lipid metabolism‐related genes expressions (D). The data were presented as means ± SDs. Compared with Control group: # P < .05, ## P < .01, ### P < .001. Compared with Model group: *P < .05, **P < .01, ***P < .001 (n = 6)